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Abstract
Background: The global pattern of varying prevalence of diseases of affluence, such as obesity,
cardiovascular disease and diabetes, suggests that some environmental factor specific to agrarian
societies could initiate these diseases.
Presentation of the hypothesis: We propose that a cereal-based diet could be such an
environmental factor. Through previous studies in archaeology and molecular evolution we
conclude that humans and the human leptin system are not specifically adapted to a cereal-based
diet, and that leptin resistance associated with diseases of affluence could be a sign of insufficient
adaptation to such a diet. We further propose lectins as a cereal constituent with sufficient
properties to cause leptin resistance, either through effects on metabolism central to the proper
functions of the leptin system, and/or directly through binding to human leptin or human leptin
receptor, thereby affecting the function.
Testing the hypothesis: Dietary interventions should compare effects of agrarian and non-
agrarian diets on incidence of diseases of affluence, related risk factors and leptin resistance. A non-
significant (p = 0.10) increase of cardiovascular mortality was noted in patients advised to eat more
whole-grain cereals. Our lab conducted a study on 24 domestic pigs in which a cereal-free hunter-
gatherer diet promoted significantly higher insulin sensitivity, lower diastolic blood pressure and
lower C-reactive protein as compared to a cereal-based swine feed. Testing should also evaluate
the effects of grass lectins on the leptin system in vivo by diet interventions, and in vitro in various
leptin and leptin receptor models. Our group currently conducts such studies.
Implications of the hypothesis: If an agrarian diet initiates diseases of affluence it should be
possible to identify the responsible constituents and modify or remove them so as to make an
agrarian diet healthier.
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Background
In this paper we look at global variation in the prevalence
of diseases of affluence [1], such as obesity, cardiovascular
disease and diabetes type 2 [2,3], between agrarian and
non-agrarian societies. This societal division refers to dif-
ferences in staple foods. The diet of an agrarian society is
based on large amount of seeds from grass such as cereals
(e.g. wheat, rice, maize). Cereals are per definition rare or
absent in a non-agrarian diet. Non-agrarian societies can
be further divided into hunter-gatherer and horticultural
societies. The diet of a hunter-gatherer society is based on
hunting, fishing and gathering wild plants and insects.
Hunting and gathering is thought to represent the original
mode of life common to all prehistoric humans during
the Palaeolithic (i.e. the Old Stone Age 2.6 million-10,
000 years ago) [4,5]. Horticultural societies obtain the
bulk of their food from gardening, which sometimes
implies heavy dependence on a single starchy cultivar
such as a root crop (e.g. manioc).
Global epidemiologic pattern
Among agrarian societies there is considerable variation
both in time and place in the prevalence of diseases of
affluence [6-8]. The cause behind the initiation and pro-
gression of diseases of affluence are most certainly multi-
factorial and probably several factors need to be present to
a sufficient degree for these diseases to appear clinically.
Among agrarian societies some diseases of affluence, such
as obesity and type 2 diabetes, are associated with increas-
ing westernization and urbanization, although some less
westernized countries such as China and countries in sub-
Saharan Africa did have more cases of diabetes in rural
than urban areas in 1995 [6,7]. Several risk factors for
obesity and diabetes type 2, such as low physical activity
and a sedentary lifestyle with prolonged TV watching, are
thus associated with westernization and urbanization,
which perhaps explain their association with these dis-
eases [9]. However, for other diseases of affluence, such as
stroke and CHD, some of the varying prevalence among
agrarian societies is puzzling with no consistent associa-
tion with westernization, urbanization or rise in risk fac-
tors [8,10]. Indeed, CHD was reportedly rare in developed
populations until the early 1900s with major increases in
the occurrence and mortality rate from the disease in the
1930s, but with as much as five-fold differences in CHD
mortality rates between European countries such as
Poland and Spain [8]. Some of these differences in time
and place may be explained by variation in known risk
factors [11,12]. A few agrarian societies, like the Amazon-
dwelling Brazilian Indian tribe Amondava, reportedly
lack diseases of affluence, which possibly is due to a recent
and small shift in diet incorporating small amounts of
cereals in an otherwise non-agrarian diet [13]. Such a pat-
tern of differentially delayed onset of the various diseases
of affluence has been described [2]. However, the global
epidemiological pattern suggests that almost all agrarian
societies have some prevalence of diseases of affluence. In
contrast, diseases of affluence have been virtually absent
among many non-agrarian societies in Melanesia, Malay-
sia, Africa, South America and the Arctic [2,5,14]. One
such traditional population are the horticultural Trobri-
and Islanders with a mortality from atherothrombotic cir-
culatory diseases which apparently is close to zero, even
though they have access to abundant sources of food,
smoke heavily and have a fair share of elderly people
[2,14]. These disproportionate differences between agrar-
ian and non-agrarian societies are even larger with regard
to the incidence of non-infectious stroke [10,15]. Moreo-
ver, when people living in non-agrarian societies migrate
to an agrarian society or when their own society becomes
agrarian they contract diseases of affluence [2,14], which
illustrates the general rule that there is no genetic protec-
tion against diseases of affluence, only genetic variation in
degree of susceptibility [2].
The global epidemiological pattern of varying prevalence
of diseases of affluence thus suggests that some environ-
mental factors specific to agrarian societies could initiate
these diseases. There are many such candidate environ-
mental factors, and in this paper we study cereals, the
clearest defining dietary difference between an agrarian
and non-agrarian diet. Since nothing in biology makes
sense except in the light of evolution [16], we look at the
cereal component of human diet from an evolutionary
perspective.
Human diet and evolution
The grasses emerged between 65 and 55 million years ago
[17]. Since the last common ancestor of living primates,
including humans, emerged before this time, some 90 to
65 million years ago, it cannot have had a diet consisting
of seeds from grass [18,19]. Subsequent evolution of our
primate ancestors up until 4–8 million years ago is
thought to have taken place in the trees [20-23], where
almost all potential plant food comes from dicotyledo-
nous species [24] and the monocotyledonous grasses are
absent [17]. The archaeological evidence during the last
four million years of evolution towards Homo sapiens sug-
gests that if grass seeds were being incorporated into the
diet of our ancestors, they probably only contributed a
small part [25]. Homo sapiens emerged about 200,000
years ago [26,27], and seeds from grass were probably not
key dietary staples of Homo sapiens hunter-gatherers [28].
About 10,000 years ago (e.g. 500 generations) some pop-
ulations invented agriculture [28], and their descendents
possibly have some genetic adaptation to an agrarian diet
such as lower prevalence of celiac disease and related HLA
genotypes [29,30]. However, many populations shifted to
agrarian diet more recently, between 1–100 generations
ago, which from an evolutionary perspective is a veryBMC Endocrine Disorders 2005, 5:10 http://www.biomedcentral.com/1472-6823/5/10
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short time to admit any measurable sign of adaptation
[31]. Thus, when examining human diet from an evolu-
tionary perspective, it makes sense that humans with an
evolutionary novel agrarian diet could suffer from dis-
eases of affluence due to insufficient adaptation [31].
Many metabolic factors and pathways are important in
the onset and development of diseases of affluence. When
looking for metabolic signs of such insufficient adapta-
tion, one of the more relevant associations is that between
diseases of affluence and leptin resistance, an acquired
insensitivity to high levels of leptin [32-38].
Leptin resistance
Leptin acts as a signal to the brain to inhibit food intake
and enable the storage in adipocytes of surplus calories
while simultaneously protecting peripheral non-adipose
tissue from toxic effects of intracellular lipid overload
[39]. Leptin also affects the growth of blood vessels and
bone; the immune system; glucose- and fat metabolism
and the reproductive system [32,40]. Leptin administered
peripherally in animal models such as rodents promotes
weight loss and satiation, but peripheral administration
of leptin in obese human does not promote significant
weight loss [32,41]. This difference in effect together with
the observation that most obese humans have high levels
of leptin suggest that leptin resistance causes human obes-
ity [32,41]. Sometimes end-organ resistance can be caused
by mutations in hormone receptors, which has been
described for several hormones. The pathophysiology of
acquired forms of end-organ resistance to hormones such
as insulin and leptin has been elusive [42]. The differing
results from leptin administration implies that the
detailed actions of leptin in energy metabolism are differ-
ent in humans versus experimental animals such as
rodents [43]. This difference could be genetically based
and possibly an adaptation of the human or experimental
animal leptin system to some environmental factors
affecting their respective ancient ancestors. But this differ-
ence could also be due to an insufficient adaptation to
some environmental factors, which are now affecting the
leptin system of humans or experimental animals. To
address these different possibilities we turn to recent stud-
ies on the molecular evolution of the leptin gene.
Molecular evolution of leptin
The hominoids (gibbon, orang-utan, gorilla, chimpanzee,
early human and modern human) emerged 25–30 mil-
lion years ago [19]. Studies on the molecular evolution of
leptin have shown a significant increase of non-synony-
mous to synonymous changes [31] in the ancestral line of
primates giving rise to hominoids, and this significant
increase is also relative to descendant hominoid species
such as humans [43]. This implies that the ancestral line
of primates giving rise to hominoids probably acquired
several positive non-synonymous changes of their leptin
gene due to adaptations, and that the leptin genes of
humans have not changed much since the emergence of
hominoids. Thus, based on findings from previous sec-
tion on human diet and evolution, it is very unlikely that
human leptin could be specifically adapted to an agrarian
diet. Furthermore, similar studies on molecular evolution
have shown high similarity of leptin genes in such diverse
species as mouse, rat, chicken and turkey, which was
ascribed to convergent or parallel evolution [44]. Since
many mammals, which share the same distant common
ancestor with these species, do not have similar genes, it
seems plausible that this high similarity is due to conver-
gent evolution and not parallel evolution [31]. This
implies that natural selection has caused the leptin genes
of these bird and rodent species to be highly similar by
adapting them to some similar factor(s) in the environ-
ment of their ancient ancestors. Diet is an important envi-
ronmental factor, as exemplified by primates, where it
affects basal metabolic rate, size, reproduction and loco-
motion [19]. Since leptin is a regulator of appetite, energy
metabolism and reproduction it could well be subject to
forces of natural selection due to diet. Except for a diet
containing seeds from grass, it is hard to discern an envi-
ronmental characteristic shared by diverse rodent and
bird species which is sufficient to explain such high simi-
larity of leptin genes [45-47]. Thus, it is possible that lep-
tin of these rodent and bird species are specifically
adapted to a diet including large amounts of seeds from
grass. It follows that such a diet possibly imposes prob-
lems to the human leptin system, which we have con-
cluded is not specifically adapted to such a diet. The
studies on molecular evolution of leptin thus indicate that
the differing results from leptin administration in humans
and experimental animals could be due to adaptation of
mouse and rat leptin and insufficient adaptation of
human leptin to a diet including large amounts of seeds
from grass. When looking for constituents of seeds from
grass explaining these differences, we find the properties
of lectins interesting.
Lectins
Lectins are proteins abundant in the virus, bacteria, ani-
mal and plant kingdom, which bind reversibly to specific
sugar structures (for most references and background see
[48,49]). Different classes of plants, such as mono- and
dicotyledonous, have different classes of lectins with dif-
fering biochemical properties, and there is a subclass of
lectins only found in grasses like cereals. Many plant
lectins are thought to play a role in the plants defence
against being eaten. Accordingly, plant lectins have an
obvious preference for binding to sugar structures of ani-
mal, fungal or microbial origin, and are usually at highest
concentrations in plant parts essential for reproductive
success such as seed germs. The intensively studied lectin
wheat germ agglutinin (WGA), which protects againstBMC Endocrine Disorders 2005, 5:10 http://www.biomedcentral.com/1472-6823/5/10
Page 4 of 7
(page number not for citation purposes)
insects and fungi [49], is present in wheat seed in both the
germ and the gluten part of endosperm [50]. Peptides
behaving in a lectin-like manner have also been obtained
upon cleavage of gliadin in gluten [51]. Sourdough lactic
acid bacteria hydrolyse gliadin peptides and inhibit their
lectin-like behaviour [52], which perhaps explains some
of the unexplained health effects of probiotics [53]. White
flour consumed by humans contains a high proportion of
gluten and has agglutinating activity suggestive of lectins
[54-57]. Thus, lectins are present in our food, they are
heat-stable and resistant to breakdown in the gastrointes-
tinal tract, they bind to the surface epithelium of the
digestive tract and they can lead to anti-nutritional, mild
allergic or other subclinical effects in humans and animals
[48,49]. Lectins can also be transported through the gut
wall into the blood circulation, where they directly influ-
ence peripheral tissues and body metabolism through the
binding to glycosylated structures, such as the insulin
receptor, the epidermal growth factor receptor and the
interleukin 2 receptor [57-65]. WGA have effects on acti-
vation of the epidermal growth factor receptor [61],
mitogenesis [66], agglutination of red blood cells [48],
activation of platelets and cell adhesion molecules [67]
and vascular permeability [68-70]. WGA also have several
effects related to autoimmunity, allergy and inflammation
[57,71]. WGA binds to several types of mammalian cells
including pancreatic duct epithelial cells [72], prostatic
cancer cells [73], arterial macrophages and smooth mus-
cle cells [74,75], glomerular capillary walls, mesangial
cells and tubules of human kidney [59]. Human serum
contains antibodies against WGA and lectins of soybean
and peanut [76]. Hence, lectins have sufficient properties
to affect the leptin system indirectly, through effects on
metabolism central to the proper function of the leptin
system, and possibly also directly through interaction
with leptin or the leptin receptor. The intriguing possibil-
ity of a direct interaction between lectin and the leptin sys-
tem is worth some additional comments.
Possible direct interaction between lectin and the leptin 
system
The studies on molecular evolution of leptin indicated
adaptation of rodent leptin and insufficient adaptation of
human leptin to a diet including large amounts of seeds
from grass. This adaptation and lack thereof could also
involve the leptin receptor, since leptin and leptin recep-
tor coevolves due to interdependency for signalling. An
adaptation of the leptin gene could thus be to avoid dis-
turbed function of either leptin or the leptin receptor. It
would be interesting to see results from studies on molec-
ular evolution of the leptin receptor, but such studies are
unfortunately lacking. However, when considering direct
lectin interaction with leptin or the leptin receptor, this
interaction could be with either or with both. Lectins
binding to sugar structures of a membrane receptor can
mimic or block the effect of the physiological ligand
[48,61,62,65,77-82]. Leptin is not glycosylated, but the
leptin receptor is and lectins binding to different leptin
receptor glycosylations might explain different leptin
binding affinity [83,84], as observed by Livingston and
Purvis in their study on WGA and the insulin receptor
[63]. Thus, dietary lectins could possibly bind to the lep-
tin receptor and affect its function, which could translate
into diseases of affluence as indicated by studies on effects
of single nucleotide polymorphisms on the function of
leptin and the leptin receptor [85-91].
Presentation of the hypothesis
The global pattern of varying prevalence of diseases of
affluence suggests that some environmental factor specific
to agrarian societies could initiate these diseases [2,14].
We propose that cereals, the clearest defining dietary dif-
ference between an agrarian and non-agrarian diet, could
be such an environmental factor. Through previous stud-
ies in archaeology [17-25,28,31] and molecular evolution
[43,44] we conclude that humans and human leptin sys-
tem are not specifically adapted to a cereal-based diet, and
that leptin resistance associated with diseases of affluence
[32-38] could indicate insufficient adaptation to such a
diet. As for the constituent(s) of cereals causing leptin
resistance as a sign of insufficient adaptation, we propose
lectins as a candidate with sufficient properties. Cereal
lectins are specific to cereals [48,49], they are present in
our food [50,51,54-57], they enter our systemic circula-
tion and have many reported effects in our body including
the binding to receptors, such as the insulin receptor, the
epidermal growth factor receptor and the interleukin 2
receptor [48,57-75]. Cereal lectins could thus cause leptin
resistance either indirectly, through effects on metabolism
central to the proper functions of the leptin system, and/
or directly, through binding to human leptin or leptin
receptor, thereby affecting the function. The intriguing
possibility of direct interaction between lectin and the lep-
tin receptor could alter the function of the leptin receptor
and translate into diseases of affluence [48,61-63,65,77-
82,84-91].
Testing the hypothesis
The hypothesis that an agrarian diet could initiate diseases
of affluence should ideally be tested in prospective diet
interventions comparing this diet with non-agrarian diets.
Hard end-points should be various diseases of affluence
and soft end-points should be their respective risk factors,
specifically including leptin resistance. The only relevant
human controlled intervention trial with hard end-points
that we are aware of found a non-significant (p = 0.10)
increase of cardiovascular mortality in CHD patients who
were advised to eat more whole-grain cereals compared to
those who were not advised to eat more whole-grain cere-
als [92]. We performed a trial on 24 domestic pigs inBMC Endocrine Disorders 2005, 5:10 http://www.biomedcentral.com/1472-6823/5/10
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which a cereal-free hunter-gatherer diet promoted signifi-
cantly higher insulin sensitivity, lower diastolic blood
pressure and lower C-reactive protein as compared to a
cereal-based swine feed (submitted). A prospective obser-
vational study on intake of refined grains as part of a
"western diet" pattern showed a positive association with
increased risk for type 2 diabetes [93]. Although the foods
with major contributions to the "western diet" pattern
were all positively associated with increased risk for type 2
diabetes, the consumption of refined grains remained sig-
nificantly associated with the risk for type 2 diabetes when
the foods with major contributions were modelled simul-
taneously [93]. However, the same study also showed a
reduced risk for type 2 diabetes with a high intake of
whole grain as part of a "prudent" diet pattern [93], and
whole grains are reportedly also inversely related to
weight gain, even after multivariate analysis for several
indicators of a healthy living such as non-smoking and
physical activity [94]. Accordingly, there are contradictory
results from studies on effects of cereal grains on diseases
of affluence. If not due to confounding factors, this is pos-
sibly explained by beneficial effects of whole grains as
compared to refined grains, including higher fiber and
micronutrient content, coupled with the usually inverse
relationship between intake of whole and refined grain
[94].
Evaluating the effects of grass lectins on the leptin system
in vivo by diet interventions or in vitro in various leptin
and/or leptin receptor models could test the hypothesis
that cereal lectins might be the cause of leptin resistance.
Our group currently conducts such studies. If dietary
lectins could inhibit leptin binding and cause leptin resist-
ance, then the proportion of leptin bound to the soluble
leptin receptor in plasma should be lower in more leptin
resistant humans on an agrarian diet, and this proportion
should also increase with lower intake of dietary lectins.
This is supported by the observations that the proportion
of leptin bound to the soluble leptin receptor in plasma is
lower in supposedly leptin resistant obese humans [95],
and that this proportion increases after fasting in obese
but not in lean humans [96]. The fasting state is obviously
not an ideal situation for a direct comparison of the differ-
ent effects of agrarian and non-agrarian diets, but in the
absence of such studies fasting should cause less agrarian
lectins to inhibit leptin binding. Further support comes
from earlier studies from our laboratory on leptin levels in
populations at a transitional stage from gathering to agri-
cultural systems [97,98]. In addition, the recent finding
that total leptin and free leptin both correlate with the die-
tary carbohydrate content, whereas bound leptin is associ-
ated with resting energy expenditure [99], seem to support
our hypothesis.
Implications of the hypothesis
If an agrarian diet initiates diseases of affluence it should
be possible to identify the responsible constituents and
modify or remove them so as to make the agrarian diet
healthier. Furthermore, in animal experiments, the possi-
ble species-specific differences in adaptation to diets out-
lined in this article and their effects on studied parameters
should be kept in mind when choosing the animal and
the animal feed for the study. Furthermore, if cereal lectins
should appear to have significant effects on human
metabolism, then it is suggested that other plant lectins
like peanut-lectin should be investigated in this regard as
well.
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